Cargando…
Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer
BACKGROUND: Epithelial ovarian cancer (EOC) is the fifth most common cause of cancer death in women. Due to a lacking of early detection method, its five-year survival rate is only 30%. Nevertheless, novel biomarkers for diagnosis remain to be discovered. The potential of microRNA signatures in the...
Autores principales: | Hu, Yingchao, Zhu, Yapei, Zhang, Wen, Lang, Jinghe, Ning, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859958/ https://www.ncbi.nlm.nih.gov/pubmed/32009804 http://dx.doi.org/10.2147/OTT.S211413 |
Ejemplares similares
-
Circular RNA circBNC2 inhibits epithelial cell G2-M arrest to prevent fibrotic maladaptive repair
por: Wang, Peng, et al.
Publicado: (2022) -
Circular RNA circBNC2 facilitates glycolysis and stemness of hepatocellular carcinoma through the miR-217/high mobility group AT-hook 2 (HMGA2) axis
por: Feng, Yan, et al.
Publicado: (2023) -
Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer
por: Ning, Li, et al.
Publicado: (2022) -
Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer
por: Ning, Li, et al.
Publicado: (2022) -
Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular Carcinoma
por: Wu, Yali, et al.
Publicado: (2016)